| 2026-08-01 | ai-drug-discovery | Innovative strategies for anti-fibrotic drugs discovery from traditional Chinese medicine. | Chinese herbal medicines | 57.8 | PMID, DOI |
| 2026-08-01 | ai-drug-discovery | Conditional superiorities and unaddressed bottlenecks: a critical review of artificial intelligence for waterborne microbial detection. | Applied microbiology and biotechnology | 54.9 | PMID, DOI |
| 2026-08-01 | ai-drug-discovery | AI-driven discovery of multifunctional peptides: From sequence space to therapeutics. | Biotechnology advances | 54.7 | PMID, DOI |
| 2026-08-01 | de-novo-protein-design | The past, present and future of de novo protein design. | Nature | 73.9 | PMID, DOI |
| 2026-08-01 | de-novo-protein-design | Evaluating generalization in protein-ligand cofolding methods. | Nature structural & molecular biology | 59.9 | PMID, DOI |
| 2026-08-01 | de-novo-protein-design | Bioinformatic and computational biophysics tools for nanopore engineering: a review from standard approaches to machine learning advancements. | Journal of nanobiotechnology | 59.3 | PMID, DOI |
| 2026-08-05 | ai-drug-discovery | Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH. | International journal of molecular sciences | 54.6 | PMID, DOI |
| 2026-08-05 | de-novo-protein-design | FLOWR: flow matching for structure-aware de novo, interaction- and fragment-based ligand generation. | Nature computational science | 58.7 | PMID, DOI |
| 2026-08-07 | ai-drug-discovery | Multi-organ AI endophenotypes chart the heterogeneity of brain, eye and heart pan-disease. | Nature. Mental health | 55.8 | PMID, DOI |
| 2026-08-08 | ai-drug-discovery | Artificial intelligence in drug discovery - what it is, where we stand and the path forward. | Nature reviews. Drug discovery | 54.8 | PMID, DOI |
| 2026-08-09 | ai-drug-discovery | Artificial intelligence catalyzes antimicrobial peptide design. | Synthetic and systems biotechnology | 56.4 | PMID, DOI |
| 2026-08-12 | ai-drug-discovery | Drug Discovery's Blind Spot: Why Organoid-Artificial Intelligence Convergence Demands Integrated Governance. | The American journal of bioethics : AJOB | 60.0 | PMID, DOI |
| 2026-08-12 | ai-drug-discovery | Hangzhou declaration on the global development of artificial intelligence in traditional Chinese medicine. | Journal of integrative medicine | 56.3 | PMID, DOI |
| 2026-08-13 | Biomedical Research | CRISPR-Cas9 gene editing: A revolutionary tool for precision medicine | Nature | 95.8 | PMID, DOI |
| 2026-08-13 | Biomedical Research | Machine learning approaches for drug discovery and development | Nature Biotechnology | 92.3 | PMID, DOI |
| 2026-08-13 | Biomedical Research | COVID-19 vaccine efficacy and safety in real-world populations | New England Journal of Medicine | 98.1 | PMID, DOI |
| 2026-08-15 | ai-drug-discovery | Advancing cancer drug discovery through the integration of machine learning and high-throughput screening. | Future medicinal chemistry | 38.5 | PMID, DOI |
| 2026-08-15 | de-novo-protein-design | Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms. | Computational and structural biotechnology journal | 40.8 | PMID, DOI |
| 2026-08-15 | de-novo-protein-design | Decoding bacterial transcriptional regulatory networks through integrated multi-omics datasets for artificial intelligence-driven design of programmable biological systems. | Current opinion in biotechnology | 38.7 | PMID, DOI |